Skip to main content

Table 2 SUV metrics: means ± standard deviation

From: What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours

 NHLHLSarcoma
SUVmax14.15 ± 6.85 [11.32–16.98]11.82 ± 4.30 [9.33–14.30]8.36 ± 4.45 [6.27–10.44]
SUVpeak11.86 ± 6.42 [9.22–14.51]9.72 ± 3.84 [7.51–11.94]6.72 ± 3.27 [5.19–8.25]
SUVmax/liver9.61 ± 4.29 [7.84–11.38]6.78 ± 2.40 [5.39–8.17]6.06 ± 2.53 [4.88–7.24]
SUVmax/mediastinum13.52 ± 6.86 [10.69–16.36]9.76 ± 3.70 [7.62–11.90]9.78 ± 4.98 [7.45–12.11]
SUVpeak/liver8.09 ± 4.11 [6.40–9.79]5.54 ± 2.13 [4.32–6.77]4.87 ± 1.94 [3.96–5.78]
SUVpeak/mediastinum11.39 ± 6.31 [8.78–13.99]7.93 ± 3.06 [6.17–9.70]7.81 ± 3.69 [6.09–9.54]
  1. NHL non-Hodgkin lymphoma, HL Hodgkin lymphoma. In brackets: 95% confidence interval